Diabetes, a perennial disease found all over the world has inflicted more than 150 million people. Of this 90% suffer from type 2 diabetes. In US alone 5 to 6% (about 16 million) people suffer from ty
March 21, 2006 (Press Release) --
Diabetes, a perennial disease found all over the world has inflicted more than 150 million people. Of this 90% suffer from type 2 diabetes. In US alone 5 to 6% (about 16 million) people suffer from type 2 diabetes. Although there is a routine practice to diagnose diabetes yet only half of the diabetic patients are detected.
Type 2 diabetes is a metabolic disorder in which the insulin secretory response to glucose is hindered. It also hinders stimulation of glucose uptake by muscles and restrains hepatic glucose production. All these together raise blood glucose levels. As a result this impairment can damage organs like the kidneys, nervous system, eyes and circulatory system.
Other problems of type 2 diabetes are obesity, elevated blood pressure, and high levels of blood lipids. About 80 % of the type 2 diabetic patients are overweight. Obesity is one of the foremost indications of a person being diabetic. Obesity is excess fat in the body, usually defined in terms of the body mass index (BMI), whereby a person with a BMI of greater than 30 kg/m square is considered obese.
Today most people with diabetes are only medically treating the symptoms and not getting to the root of the problem. This cause more problems and it typically reveal fundamental difference in modalities. Thus the best way to control diabetes is to arrest the causal actions.
A market research report by RNCOS named “Insulin Delivery System – The State of the Science & Market Opportunities” deals about the disease and its associated drug. According to the report it is predicted that the insulin drug market is projected to grow to 26.8Bn USD by 2008 up from 12.4Bn USD in 2002. The report also indicates a global distribution of insulin drug sales. Of the drug sales of 8.0Bn USD, about 4.8Bn USD were of Oral Anti Diabetes while 2.95Bn USD were from insulin sales.
As the share of sales is growing at a CAGR (Cumulative Annual Growth Rate) of 14%, there is a bright future for Global Insulin Market as predicted by the report analysts. Also the worldwide market for diabetes therapeutics and diagnostics, contributing 15Bn USD in 2004 to world economy would more than double itself at 32Bn USD by 2008.
The market research report, “Insulin Delivery System – The State of the Science & Market Opportunities” have done an assessment of the forces driving the market both extensively and intensively. This drive is induced by the threat against expiration of existing patients and entry of more research firms conducting R&D to lower the prices of these drugs.
About RNCOS:
RNCOS, formed in 2002, offers Market Research Reports for your business needs and aims to put an end to your information pursuit. Our expertise in gathering global business information for industry research, corporate training, growth consulting, and business consulting, brings reputed companies and firms to us for business enhancement solutions. We can be your one-stop-shop for Industry research information and niche market analysis.
To purchase your copy: http://www.marketsmonitor.com/category/Biotech06.html
For more information about the report please visit www.marketsmonitor.com
Type 2 diabetes is a metabolic disorder in which the insulin secretory response to glucose is hindered. It also hinders stimulation of glucose uptake by muscles and restrains hepatic glucose production. All these together raise blood glucose levels. As a result this impairment can damage organs like the kidneys, nervous system, eyes and circulatory system.
Other problems of type 2 diabetes are obesity, elevated blood pressure, and high levels of blood lipids. About 80 % of the type 2 diabetic patients are overweight. Obesity is one of the foremost indications of a person being diabetic. Obesity is excess fat in the body, usually defined in terms of the body mass index (BMI), whereby a person with a BMI of greater than 30 kg/m square is considered obese.
Today most people with diabetes are only medically treating the symptoms and not getting to the root of the problem. This cause more problems and it typically reveal fundamental difference in modalities. Thus the best way to control diabetes is to arrest the causal actions.
A market research report by RNCOS named “Insulin Delivery System – The State of the Science & Market Opportunities” deals about the disease and its associated drug. According to the report it is predicted that the insulin drug market is projected to grow to 26.8Bn USD by 2008 up from 12.4Bn USD in 2002. The report also indicates a global distribution of insulin drug sales. Of the drug sales of 8.0Bn USD, about 4.8Bn USD were of Oral Anti Diabetes while 2.95Bn USD were from insulin sales.
As the share of sales is growing at a CAGR (Cumulative Annual Growth Rate) of 14%, there is a bright future for Global Insulin Market as predicted by the report analysts. Also the worldwide market for diabetes therapeutics and diagnostics, contributing 15Bn USD in 2004 to world economy would more than double itself at 32Bn USD by 2008.
The market research report, “Insulin Delivery System – The State of the Science & Market Opportunities” have done an assessment of the forces driving the market both extensively and intensively. This drive is induced by the threat against expiration of existing patients and entry of more research firms conducting R&D to lower the prices of these drugs.
About RNCOS:
RNCOS, formed in 2002, offers Market Research Reports for your business needs and aims to put an end to your information pursuit. Our expertise in gathering global business information for industry research, corporate training, growth consulting, and business consulting, brings reputed companies and firms to us for business enhancement solutions. We can be your one-stop-shop for Industry research information and niche market analysis.
To purchase your copy: http://www.marketsmonitor.com/category/Biotech06.html
For more information about the report please visit www.marketsmonitor.com
Email
Print
SPAM
